Literature DB >> 11958519

Effect of R-(-)-deprenyl and harmaline on dopamine- and peroxynitrite-induced membrane permeability transition in brain mitochondria.

Chung Soo Lee1, Chung Seok Lee, Hyun Hee Ko, Jin Ho Song, Eun Sook Han.   

Abstract

The present study examined the effect of MAO inhibitors, deprenyl and harmaline, on the membrane permeability transition in brain mitochondria. Deprenyl, harmaline, and antioxidant enzymes (SOD and catalase) attenuated alteration of the swelling, membrane potential, cytochrome c release, and Ca2+ transport in mitochondria treated with dopamine. In contrast, deprenyl and harmaline did not reduce the peroxynitrite-induced change in membrane permeability. Deprenyl and harmaline inhibited the decrease in thioredoxin reductase activity and the thiol oxidation in mitochondria treated with dopamine but did not decrease the effect of peroxynitrite. Deprenyl and harmaline significantly decreased the formation of melanin from dopamine. The results suggest that deprenyl and harmaline may protect brain mitochondria against the toxic action of dopamine oxidation by the maintenance of thioredoxin reductase activity, inhibition of thiol oxidation, and inhibition of dopamine oxidation product formation. In contrast, MAO inhibitors may not defend brain mitochondria against damaging action of peroxynitrite.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11958519     DOI: 10.1023/a:1014832520809

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  Dual responses of CNS mitochondria to elevated calcium.

Authors:  N Brustovetsky; J M Dubinsky
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

2.  Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.

Authors:  D Offen; I Ziv; A Barzilai; S Gorodin; E Glater; A Hochman; E Melamed
Journal:  Neurochem Int       Date:  1997-08       Impact factor: 3.921

3.  Modulation of brain mitochondrial membrane permeability and synaptosomal Ca2+ transport by dopamine oxidation.

Authors:  K J Kim; Y Y Jang; E S Han; C S Lee
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

4.  Nitric oxide production and mitochondrial dysfunction during rat thymocyte apoptosis.

Authors:  J Bustamante; G Bersier; M Romero; R A Badin; A Boveris
Journal:  Arch Biochem Biophys       Date:  2000-04-15       Impact factor: 4.013

5.  Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells.

Authors:  D H Kim; Y Y Jang; E S Han; C S Lee
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

6.  Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release.

Authors:  P S Brookes; E P Salinas; K Darley-Usmar; J P Eiserich; B A Freeman; V M Darley-Usmar; P G Anderson
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

7.  Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease.

Authors:  D A Gearhart; M A Collins; J M Lee; E J Neafsey
Journal:  Neurobiol Dis       Date:  2000-06       Impact factor: 5.996

Review 8.  Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration.

Authors:  W G Tatton; R M Chalmers-Redman
Journal:  Neurology       Date:  1996-12       Impact factor: 9.910

9.  The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.

Authors:  D S Cassarino; J K Parks; W D Parker; J P Bennett
Journal:  Biochim Biophys Acta       Date:  1999-01-06

10.  Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles.

Authors:  J J Poderoso; M C Carreras; C Lisdero; N Riobó; F Schöpfer; A Boveris
Journal:  Arch Biochem Biophys       Date:  1996-04-01       Impact factor: 4.013

View more
  3 in total

1.  Rasagiline prevents apoptosis induced by PK11195, a ligand of the outer membrane translocator protein (18 kDa), in SH-SY5Y cells through suppression of cytochrome c release from mitochondria.

Authors:  Makoto Naoi; Wakako Maruyama; Hong Yi
Journal:  J Neural Transm (Vienna)       Date:  2013-05-17       Impact factor: 3.575

Review 2.  Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases.

Authors:  Yew Rong Kong; Kai Ching Tay; Yi Xiang Su; Choon Kwang Wong; Wen Nee Tan; Kooi Yeong Khaw
Journal:  Molecules       Date:  2021-01-30       Impact factor: 4.411

Review 3.  Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.